Silk Road Medical, Inc (SILK)
27.49
0.00 (0.00%)
Inactive · Last trade price on Sep 17, 2024
Silk Road Medical Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Net Income | -56.54 | -55.74 | -55.01 | -49.81 | -47.37 | -52.42 |
Depreciation & Amortization | 3.73 | 3.79 | 3.17 | 1.92 | 1.39 | 1.29 |
Other Amortization | 0.24 | 0.23 | 0.22 | 0.16 | 0.07 | 0.05 |
Loss (Gain) From Sale of Assets | 0.02 | 0.16 | 0.18 | 0.01 | 0.05 | - |
Loss (Gain) From Sale of Investments | -5.54 | -6.5 | -1.42 | 0.58 | 0.3 | -0.31 |
Stock-Based Compensation | 41.26 | 38.89 | 25.02 | 14.61 | 7.23 | 2.98 |
Provision & Write-off of Bad Debts | 0.03 | 0.05 | -0 | 0.01 | -0.03 | 0.02 |
Other Operating Activities | 1.36 | 1.02 | 1.29 | 0.08 | -2.34 | 21.82 |
Change in Accounts Receivable | -4.75 | -5.61 | -6.17 | -2.77 | -0.44 | -2.24 |
Change in Inventory | -11.15 | -10.78 | -1.45 | -5.56 | -2.16 | -4.7 |
Change in Accounts Payable | -1.89 | 3.06 | 0.97 | -1.16 | 0.59 | 0.62 |
Change in Other Net Operating Assets | -0.72 | -0.59 | 0.63 | 3.01 | 0.63 | 3.28 |
Operating Cash Flow | -33.96 | -32.01 | -32.58 | -38.94 | -42.07 | -29.61 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Capital Expenditures | -2.13 | -1.51 | -5.01 | -4.76 | -0.84 | -0.54 |
Sale of Property, Plant & Equipment | - | - | - | 0 | - | - |
Investment in Securities | 16.07 | -5.67 | -157.06 | 77.4 | -8.55 | -69.42 |
Investing Cash Flow | 13.94 | -7.18 | -162.07 | 72.64 | -9.39 | -69.96 |
Financing Activities
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Long-Term Debt Issued | - | - | 73.91 | - | 48.51 | - |
Long-Term Debt Repaid | - | - | -49 | - | -40 | - |
Net Debt Issued (Repaid) | - | - | 24.91 | - | 8.51 | - |
Issuance of Common Stock | 14.25 | 3.89 | 114.79 | 6.95 | 75.74 | 111.97 |
Other Financing Activities | - | - | - | 0.03 | -2.5 | - |
Financing Cash Flow | 14.25 | 3.89 | 139.7 | 6.98 | 81.75 | 113.76 |
Net Cash Flow
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Net Cash Flow | -5.76 | -35.3 | -54.95 | 40.69 | 30.29 | 14.19 |
Free Cash Flow
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Free Cash Flow | -36.08 | -33.52 | -37.59 | -43.69 | -42.91 | -30.15 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | -18.85% | -18.92% | -27.11% | -43.06% | -57.04% | -47.58% |
Free Cash Flow Per Share | -0.92 | -0.86 | -1.05 | -1.26 | -1.30 | -1.31 |
Levered Free Cash Flow | -15.35 | -12.13 | -18.66 | -24.38 | -23.21 | -19.66 |
Unlevered Free Cash Flow | -11.27 | -8.07 | -15.69 | -22.96 | -20.51 | -16.61 |